Patterns of motor and non-motor features in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 8, 2009, Pages 846-850

  Van Rooden, S M ^a   Visser, M ^a   Verbaan, D ^a   Marinus, J ^a   Van Hilten, J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ANTIPARKINSON AGENT;

ADULT; ARTICLE; ATTENTION DISTURBANCE; AUTONOMIC DYSFUNCTION; BRADYKINESIA; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSKINESIA; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PARAMETER; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RIGIDITY; SYMPTOM; TREATMENT OUTCOME; TREMOR; URINARY DYSFUNCTION; AGED; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; LONGITUDINAL STUDY; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICAL MODEL;

AGED; ANTIPARKINSON AGENTS; COHORT STUDIES; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LEVODOPA; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; MOVEMENT; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 67849121577     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.166629     Document Type: Article

References (40)

1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
2. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005;5:275-83.
3. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1182-7.
4. Verbaan D, van Rooden SM, Visser M, et al. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 2008;23:35-41.
5. Ziemssen T, Reichinann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2007;13:323-32.
6. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
7. Kostic V, Przedborski S, Flaster E, et al. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 1991;41:202-5.
8. Pederzoli M, Girotti F, Scigliano G, et al. L-dopa long-term treatment in Parkinson's disease: age-related side effects. Neurology 1983;33:1518-22.
9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
10. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-7.
11. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004;75:388-95.
12. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-8.
13. Visser M, Verbaan D, van Rooden SM, et al. Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC. Mov Disord 2007;22:2221-8.
14. Visser M, Marinus J, Stiggelbout AM, et al. Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT. Mov Disord 2004;19:1306-12.
15. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
16. Marinus J, Visser M, van Hilten JJ, et al. Assessment of sleep and sleepiness in Parkinson Disease. Sleep 2003;26:1049-54.
17. Van Rooden SM, Visser M, Verbaan D, et al. Motor patterns in Parkinson's disease: A data-driven approach. Mov Disord Epub ahead of print 7 April 2009 (doi: 10.1002/mds.22512).
18. Byrne BM. Factor analytic models viewing the structure of an assessment instrument from three perspectives. J Pers Assess 2005;85:17-32.
19. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999;6:1-55.
20. Loehlin J. Latent variable models: an introduction to factor, path, and structural analysis, 3rd Edn. Mahwah, NJ: Erlbaum, 1998:74-82.
21. Comrey AL, Lee HB. A first course in factor analysis, 2nd Edn. Hillsdale NJ: Lawrence Erlbaum, 1992:242-4.
22. Bentler PM. EQS 6 structural equations program manual. Encino, CA: Multivariate Software, 2003.
23. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005;4:605-10.
24. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005;65:1863-72.
25. Kim C, Lee SJ. Controlling the mass action of alpha-synuclein in Parkinson's disease. J Neurochem 2008;107:303-6.
26. Kempster PA, Williams DR, Selikhova M, et al. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007;130:2123-8.
27. Bhidayasiri R, Truong DD. Motor complications in Parkinson disease: Clinical manifestations and management. J Neurol Sci 2008;266:204-15.
28. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(Suppl 11):S11-16.
29. Bartels AL, Balash Y, Gurevich T, et al. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J Clin Neurosci 2003;10:584-8.
30. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: Prospective assessment in the DATATOP cohort. Neurology 2001;56:1712-21.
31. Gjerstad MD, Wentzel-Larsen T, Aarsland D, et al. Insomnia in Parkinson's disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007;78:476-9.
32. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9.
33. Happe S, Ludemann P, Berger K. The association between disease severity and sleep-related problems in patients with Parkinson's disease. Neuropsychobiology 2002;46:90-6.
34. Trampus M, Ferri N, Monopoli A, et al. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat. Eur J Pharmacol 1991;194:189-94.
35. Burn DJ. Depression in Parkinson's disease. Eur J Neurol 2002;9(Suppl 3):44-54.
36. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248:151-7.
37. Levy G, Louis ED, Cote L, et al. Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol 2005;62:467-72.
38. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section. Mov Disord 1998;13:633-6.
39. Visser M, Marinus J, Stiggelbout AM, et al. Responsiveness of impairments and disabilities in Parkinson's disease. Parkinsonism Relat Disord 2006;12:314-18.
40. Martinez-Martin P, Forjaz MJ. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision. Mov Disord 2006;21:1182- 8.